WHO backs antibody treatment for high-risk Covid patients – World

WHO backs antibody treatment for high-risk Covid patients - World

PARIS: The World Health Organization (WHO) on Friday recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles. Persons with non-severe Covid-19 who are nonetheless at high risk of hospitalisation can take the antibody combo, as should critically ill patients unable to mount an adequate immune response, according to … Read more